InspireMD Company Profile (NASDAQ:NSPR)

About InspireMD (NASDAQ:NSPR)

InspireMD logoInspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Equipment, Supplies & Distribution - NEC
  • Sub-Industry: N/A
  • Symbol: NASDAQ:NSPR
  • CUSIP: N/A
  • Web: www.inspiremd.com/
Capitalization:
  • Market Cap: $3.54 million
  • Outstanding Shares: 7,421,000
Average Prices:
  • 50 Day Moving Avg: $0.53
  • 200 Day Moving Avg: $1.24
  • 52 Week Range: $0.43 - $6.25
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.32
  • P/E Growth: 0.0000
Sales & Book Value:
  • Annual Revenue: $1.9 million
  • Price / Sales: 1.86
  • Book Value: $1.13 per share
  • Price / Book: 0.42
Profitability:
  • EBIDTA: ($7,840,000.00)
  • Net Margins: -449.74%
  • Return on Equity: -174.57%
  • Return on Assets: -103.04%
Misc:
  • Average Volume: 322,584 shs.
  • Short Ratio: 2.42
 
Frequently Asked Questions for InspireMD (NASDAQ:NSPR)

What is InspireMD's stock symbol?

InspireMD trades on the NASDAQ under the ticker symbol "NSPR."

How were InspireMD's earnings last quarter?

InspireMD Inc (NASDAQ:NSPR) issued its quarterly earnings results on Tuesday, August, 9th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.17) by $0.02. The company had revenue of $0.54 million for the quarter, compared to analyst estimates of $0.80 million. InspireMD had a negative return on equity of 174.57% and a negative net margin of 449.74%. View InspireMD's Earnings History.

Who are some of InspireMD's key competitors?

Who are InspireMD's key executives?

InspireMD's management team includes the folowing people:

  • Paul S. Stuka, Chairman of the Board
  • James J. Barry Ph.D., President, Chief Executive Officer, Director
  • Isaac Blech, Independent Vice Chairman of the Board
  • Craig Shore, Chief Financial Officer, Chief Administrative Officer, Treasurer and Secretary
  • Agustin V. Gago, Executive Vice President, Chief Commercial Officer
  • Thomas J. Kester CPA, Director
  • Michael Berman, Independent Director
  • Campbell Rogers M.D., Independent Director

How do I buy InspireMD stock?

Shares of InspireMD can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is InspireMD's stock price today?

One share of InspireMD stock can currently be purchased for approximately $0.48.


MarketBeat Community Rating for InspireMD (NASDAQ NSPR)
Community Ranking:  2.8 out of 5 ( )
Outperform Votes:  32 (Vote Outperform)
Underperform Votes:  25 (Vote Underperform)
Total Votes:  57
MarketBeat's community ratings are surveys of what our community members think about InspireMD and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for InspireMD (NASDAQ:NSPR) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for InspireMD (NASDAQ:NSPR)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
3/29/2016Rodman & RenshawLower Price TargetBuy$4.00 -> $3.00N/AView Rating Details
1/7/2016HC WainwrightInitiated CoverageBuy$4.00N/AView Rating Details
(Data available from 7/23/2015 forward)

Earnings

Earnings History for InspireMD (NASDAQ:NSPR)
Earnings by Quarter for InspireMD (NASDAQ:NSPR)
Earnings History by Quarter for InspireMD (NASDAQ NSPR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/14/2016Q3 2016($0.86)$0.47 millionViewN/AView Earnings Details
8/9/2016Q216($0.17)($0.19)$0.80 million$0.54 millionViewN/AView Earnings Details
3/28/2016Q415($0.46)($0.37)$0.80 million$0.52 millionViewN/AView Earnings Details
11/10/2015Q315($0.50)($0.45)$0.63 millionViewListenView Earnings Details
8/5/2015Q215($0.05)($0.05)$0.69 millionViewN/AView Earnings Details
5/11/2015Q214($0.05)($0.08)$0.90 million$0.48 millionViewListenView Earnings Details
3/12/2015Q4 2014($0.17)($0.12)$0.07 million$0.87 millionViewN/AView Earnings Details
5/7/2014Q1 2014($0.15)($0.18)$1.65 million$1.48 millionViewN/AView Earnings Details
11/11/2013Q114($0.11)($0.09)$1.60 million$2.30 millionViewN/AView Earnings Details
9/17/2013Q413($0.13)($0.10)$1.50 million$1.50 millionViewN/AView Earnings Details
5/8/2013Q313($0.27)$1.14 million$1.51 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for InspireMD (NASDAQ:NSPR)
Current Year EPS Consensus Estimate: $-0.6100 EPS
Next Year EPS Consensus Estimate: $-0.3600 EPS

Dividends

Dividend History for InspireMD (NASDAQ:NSPR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for InspireMD (NASDAQ:NSPR)
Insider Trades by Quarter for InspireMD (NASDAQ:NSPR)
Insider Trades by Quarter for InspireMD (NASDAQ:NSPR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/21/2016Paul StukaDirectorBuy127,119$0.59$75,000.21View SEC Filing  
5/29/2014Eric L OlsonVPBuy31,778$2.55$81,033.90View SEC Filing  
5/13/2014Sol J BarerDirectorBuy50,000$2.44$122,000.00View SEC Filing  
5/12/2014Alan MilinazzoCEOBuy7,100$2.36$16,756.00View SEC Filing  
11/26/2013Asher HolzerDirectorSell597,300$2.64$1,576,872.00View SEC Filing  
11/20/2013Asher HolzerDirectorSell1,600$2.69$4,304.00View SEC Filing  
5/31/2013Sol J BarerDirectorBuy20,000$2.26$45,200.00View SEC Filing  
5/30/2013Sol J BarerDirectorBuy20,000$2.07$41,400.00View SEC Filing  
5/29/2013Alan MilinazzoCEOBuy15,000$2.11$31,650.00View SEC Filing  
5/29/2013Sol J BarerDirectorBuy20,000$2.09$41,800.00View SEC Filing  
5/28/2013Sol J BarerDirectorBuy20,000$2.15$43,000.00View SEC Filing  
5/24/2013Sol J BarerDirectorBuy20,000$2.10$42,000.00View SEC Filing  
4/25/2013Sol J BarerDirectorBuy50,000$2.00$100,000.00View SEC Filing  
4/16/2013Alan MilinazzoCEOBuy100,000$2.00$200,000.00View SEC Filing  
4/16/2013Sol J BarerDirectorBuy750,000$2.00$1,500,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for InspireMD (NASDAQ:NSPR)
Latest Headlines for InspireMD (NASDAQ:NSPR)
Source:
DateHeadline
americanbankingnews.com logoHead-To-Head Comparison: InspireMD (NSPR) vs. Cardiovascular Systems (CSII)
www.americanbankingnews.com - June 27 at 8:12 PM
finance.yahoo.com logoInspireMD Announces Completion of Transition from Exclusive European Distributor to InspireMD Managed Local Distribution Network
finance.yahoo.com - June 13 at 9:25 AM
streetinsider.com logoForm 8-K InspireMD, Inc. For: Jun 08
www.streetinsider.com - June 9 at 8:18 AM
finance.yahoo.com logoInspireMD to Present at the 2017 Marcum Microcap Conference
finance.yahoo.com - June 9 at 8:18 AM
streetinsider.com logoInspireMD (NSPR) Publishes Investigator Initiated Clinical Registry Reaffirming MGuard
www.streetinsider.com - June 8 at 9:48 AM
finance.yahoo.com logoInspireMD Announces Distribution Agreement for CGuard EPS in Taiwan
finance.yahoo.com - June 8 at 9:48 AM
finance.yahoo.com logoInspireMD Announces the Publication of an Investigator Initiated Clinical Registry Reaffirming MGuard(TM) Prime as a Highly Effective Tool to Prevent Heart Damage in Coronary Artery Blockages with High Thrombotic Content
finance.yahoo.com - June 7 at 8:29 AM
finance.yahoo.com logoInspireMD Announces Distribution Agreement for CGuard(TM) EPS in Poland
finance.yahoo.com - June 5 at 8:49 AM
finance.yahoo.com logoInspireMD Announces Appointment of Paul Stuka as Chairman of the Board
finance.yahoo.com - June 2 at 8:36 PM
finance.yahoo.com logoInspireMD to Present at the 6th Annual SeeThruEquity Microcap Investor Conference
finance.yahoo.com - May 31 at 11:04 AM
finance.yahoo.com logoInspireMD Announces First Two Patients in Hong Kong Successfully Treated with CGuard EPS
finance.yahoo.com - May 30 at 8:53 AM
finance.yahoo.com logoInspireMD's CGuard(TM) Carotid Embolic Prevention System Featured in Live Case Transmission at EuroPCR 2017
finance.yahoo.com - May 19 at 11:41 AM
finance.yahoo.com logoInspireMD Announces Publication of the IRON-GUARD Registry in EuroIntervention
finance.yahoo.com - May 17 at 6:51 PM
finance.yahoo.com logoInspireMD Announces Distribution Agreements for CGuard(TM) EPS and MGuard Prime(TM) EPS in Peru and Ecuador
finance.yahoo.com - May 15 at 10:07 AM
finance.yahoo.com logoInspireMD, Inc. :NSPR-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017
finance.yahoo.com - May 12 at 7:34 PM
finance.yahoo.com logoInspireMD Provides Business Update for the First Quarter of 2017
finance.yahoo.com - May 9 at 6:32 PM
finance.yahoo.com logoInspireMD Schedules First Quarter 2017 Earnings Conference Call
finance.yahoo.com - May 5 at 7:10 PM
finance.yahoo.com logoInspireMD Announces Distribution Agreement for CGuard(TM) EPS in Germany
finance.yahoo.com - May 1 at 12:14 PM
americanbankingnews.com logoInspireMD (NSPR) Receives Daily Media Sentiment Rating of 0.47
www.americanbankingnews.com - April 27 at 10:50 AM
finance.yahoo.com logoInspireMD Announces Distribution Agreement for CGuardTM in Turkey
finance.yahoo.com - April 7 at 11:34 AM
finance.yahoo.com logoInspireMD Announces Listing of Series B Warrants on the NYSE MKT
finance.yahoo.com - April 7 at 11:34 AM
finance.yahoo.com logoInspireMD Announces Distribution Agreement for CGuard(TM) EPS in the Netherlands
finance.yahoo.com - April 7 at 11:34 AM
us.rd.yahoo.com logoInspireMD Announces Commercial Launch of CGuard(TM) EPS in the Russian Federation at the ICCA Stroke Event in Moscow
us.rd.yahoo.com - March 30 at 7:11 PM
biz.yahoo.com logoINSPIREMD, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
biz.yahoo.com - March 29 at 9:27 AM
americanbankingnews.com logoInspireMD Inc (NSPR) to Release Quarterly Earnings on Monday
www.americanbankingnews.com - March 24 at 9:28 PM
finance.yahoo.com logoInspireMD's CGuard(TM) Carotid Embolic Prevention System to be Featured at ICCA Stroke 2017 in Moscow, Russia
finance.yahoo.com - March 23 at 7:26 PM
biz.yahoo.com logoINSPIREMD, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Other Events, Financial Statement
biz.yahoo.com - March 22 at 6:56 PM
finance.yahoo.com logoInspireMD Repays Term Note Ahead of Schedule
finance.yahoo.com - March 22 at 9:13 AM
finance.yahoo.com logoInspireMD Announces Distribution Agreement for CGuard(TM) EPS in Hong Kong
finance.yahoo.com - March 21 at 11:28 AM
finance.yahoo.com logoInspireMD Announces CGuard Distribution Agreement for the Russian Federation
finance.yahoo.com - March 20 at 9:54 AM
biz.yahoo.com logoINSPIREMD, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders, Amendments to Articles of In
biz.yahoo.com - March 15 at 7:05 PM
finance.yahoo.com logoDawson James Securities Announces the Completion of Public Offering with InspireMD Inc. for Gross Proceeds of $6,846,860
finance.yahoo.com - March 15 at 9:58 AM
finance.yahoo.com logoInspireMD Reports Continued Progress in the Transition of European Sales and Distribution
finance.yahoo.com - March 15 at 9:58 AM
finance.yahoo.com logoInspireMD Announces Closing of Public Offering of Approximately $6.8 Million
finance.yahoo.com - March 14 at 5:58 PM
us.rd.yahoo.com logoInspireMD Announces Pricing of Public Offering of up to $7.5 Million
us.rd.yahoo.com - March 9 at 6:43 PM
us.rd.yahoo.com logo9:12 am InspireMD announces the pricing of a 'best efforts' public offering of up to 1,171,875 shares of Series C Convertible Preferred Stock, Series B warrants to purchase up to 4,687,500 shares of common stock and Series C warrants to pur
us.rd.yahoo.com - March 9 at 6:43 PM
benzinga.com logoMid-Afternoon Market Update: US Stocks Turn Negative; Tailored Brands Shares Slide - Benzinga
www.benzinga.com - March 9 at 6:43 PM
seekingalpha.com logoInspireMD down 35% on equity offering - Seeking Alpha
seekingalpha.com - March 9 at 6:43 PM
biz.yahoo.com logoINSPIREMD, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
biz.yahoo.com - March 9 at 6:43 PM
finance.yahoo.com logoINSPIREMD, INC. Financials
finance.yahoo.com - February 22 at 7:00 PM
streetinsider.com logoForm 8-K InspireMD, Inc. For: Feb 15 - StreetInsider.com
www.streetinsider.com - February 21 at 5:58 PM
finance.yahoo.com logoInspireMD Provides Year End Business Update; Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016
finance.yahoo.com - February 17 at 4:33 PM
finance.yahoo.com logoInspireMD Provides Year End Business Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016
finance.yahoo.com - February 16 at 6:25 PM
finance.yahoo.com logoInspireMD Provides Year End Business Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016
finance.yahoo.com - February 16 at 6:25 PM
biz.yahoo.com logoINSPIREMD, INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - February 16 at 6:25 PM
biz.yahoo.com logoINSPIREMD, INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - February 16 at 6:25 PM
finance.yahoo.com logoInspireMD's CGuard(TM) Carotid Embolic Prevention System to be Featured at LINC 2017
finance.yahoo.com - January 24 at 8:49 AM

Social

Chart

InspireMD (NSPR) Chart for Sunday, July, 23, 2017

This page was last updated on 7/23/2017 by MarketBeat.com Staff